In patients receiving @ mg and @ mg sarilumab , neutrophil counts of @ to < @ @ ( @ ) / liter were observed in @ % and @ % of patients , respectively , while neutrophil counts of < @ @ ( @ ) / liter were observed in @ % and @ % of patients , respectively ; none of the patients receiving placebo experienced changes in neutrophil counts .